Bionomics Ltd ADR Performance
| BNOXDelisted Stock | USD 4.88 0.07 1.41% |
Bionomics holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -1.94, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Bionomics are expected to decrease by larger amounts. On the other hand, during market turmoil, Bionomics is expected to outperform it. Use Bionomics maximum drawdown, as well as the relationship between the skewness and day typical price , to analyze future returns on Bionomics.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Bionomics Ltd ADR are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Bionomics showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 12.2 M |
Bionomics |
Bionomics Relative Risk vs. Return Landscape
If you would invest 304.00 in Bionomics Ltd ADR on December 22, 2024 and sell it today you would earn a total of 184.00 from holding Bionomics Ltd ADR or generate 60.53% return on investment over 90 days. Bionomics Ltd ADR is currently generating 2.548% in daily expected returns and assumes 20.5285% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Bionomics, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Bionomics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bionomics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bionomics Ltd ADR, and traders can use it to determine the average amount a Bionomics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1241
| Best Portfolio | Best Equity | |||
| Good Returns | BNOX | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 20.53 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.55 actual daily | 51 51% of assets have lower returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Bionomics is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bionomics by adding it to a well-diversified portfolio.
Bionomics Fundamentals Growth
Bionomics Stock prices reflect investors' perceptions of the future prospects and financial health of Bionomics, and Bionomics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bionomics Stock performance.
| Return On Equity | -0.78 | |||
| Return On Asset | -0.4 | |||
| Operating Margin | 89.10 % | |||
| Current Valuation | 14.16 B | |||
| Shares Outstanding | 1.63 M | |||
| Price To Book | 829.81 X | |||
| Price To Sales | 386.72 X | |||
| Revenue | 20 K | |||
| EBITDA | (9.84 M) | |||
| Cash And Equivalents | 33.56 M | |||
| Cash Per Share | 4.46 X | |||
| Total Debt | 272.74 K | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 1.32 X | |||
| Cash Flow From Operations | (14.68 M) | |||
| Earnings Per Share | (14.32) X | |||
| Total Asset | 27.65 M | |||
| Retained Earnings | (177.98 M) | |||
About Bionomics Performance
Evaluating Bionomics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Bionomics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bionomics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia. Bionomics is traded on NASDAQ Exchange in the United States.Things to note about Bionomics ADR performance evaluation
Checking the ongoing alerts about Bionomics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bionomics ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bionomics ADR is now traded under the symbol NEUP. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Bionomics ADR is not yet fully synchronised with the market data | |
| Bionomics ADR is way too risky over 90 days horizon | |
| Bionomics ADR appears to be risky and price may revert if volatility continues | |
| Bionomics ADR has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 20 K. Net Loss for the year was (15.49 M) with loss before overhead, payroll, taxes, and interest of (18.96 M). | |
| Bionomics Ltd ADR currently holds about 33.56 M in cash with (14.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.46. | |
| Roughly 34.0% of the company shares are held by company insiders |
- Analyzing Bionomics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bionomics' stock is overvalued or undervalued compared to its peers.
- Examining Bionomics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bionomics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bionomics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bionomics' stock. These opinions can provide insight into Bionomics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Bionomics Stock
If you are still planning to invest in Bionomics ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |